McAlpine's Multiple Sclerosis, 5th Edition

• Discusses recent advances in both diagnosis and management, including improved understanding of MS in childhood and the elderly, anti-MOG disease, treatments of progressive MS, remyelination and neuroprotective therapies, and more
• Offers authoritative reviews of the current literature, placed in historical context
• Features more than 550 high-quality illustrations clarifying important scientific and clinical concepts
• Provides the most authoritative and comprehensive history of the understanding of the disease
• Uses a remarkably clear presentation to make complicated data easier to understand
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Alasdair Coles,Professor, Neuroimmunology, University of Cambridge, Cambridge UK;V. Wee Yong,Professor of Translational Neuroscience, Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary, Canada;Alastair Compston,Professor of Neurology, University of Cambridge, Cambridge, UK;Ruth Dobson,MBBS, PhD;Benjamin M. Jacobs,;Hans Lassmann,;Catherine Lubetzki,Professor of Neurology, Pierre and Marie Curie University, head, Department of Neurological Diseases, Salpêtrière Hospital, France;Maria A. Rocca,IRCCS San Raffaele Scientific Institute Vita-Salute San Raffaele University, Italy;Steve Vucic,Director, Brain and Nerve Research Center, The University of Sydney; Concord General and Repatriation Hospital, NSW, Australia;Brian Weinshenker,Professor of Neurology, University of Virginia, USA